GeneNews Reports Q1 Revenue Increase, Inks US Partnership for Cancer Tests

May 11, 2017

|

NEW YORK (GenomeWeb) – GeneNews reported today a doubling of its first quarter revenues, and announced that it has signed a US partnership agreement for its portfolio of early cancer detection tests with lab testing services provider Any Lab Test Now (ALTN).

For the three-month period ended March 31, GeneNews' revenues climbed to $200,000 from $100,000.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Menu

GeneNews Reports Q1 Revenue Increase, Inks US Partnership for Cancer Tests

To read the full story....

Breaking News

Hologic Completes $950M Senior Notes Offering

Zymo Research Gets CE-IVD Mark for Sample Collection Devices

Angle Files De Novo FDA Submission for CTC Collection Device in Breast Cancer

LabCorp, Genfit Partner to Commercialize Liver Disease Diagnostic Test

FDA Reissues Emergency Use Authorization for Hologic SARS-CoV-2 Assay for Asymptomatic Testing

Quotient Limited Gets FDA Emergency Use Authorization for Coronavirus Antibody Test

Featured White Papers

Moving from Non-Invasive Prenatal Screening to Prenatal Diagnostics: An Expert Panel Discussion

Navigating the FDA's EUA Process for Diagnostics in the Present and Future: A Stakeholder Panel Discussion

What's Popular?

FDA Reissues Emergency Use Authorization for Hologic SARS-CoV-2 Assay for Asymptomatic Testing

Cepheid Multiplex SARS-CoV-2, Flu, RSV Test Nabs FDA Emergency Use Authorization

ASU Team Wins $6M in Government Funding to Develop Rapid Saliva Testing System for Coronavirus

Israeli Startup LessTests Uses Single-Step Pooling Software to Multiply COVID-19 Testing Capacity

Abacus Diagnostica Readying Multiplex RT-PCR Test for SARS-CoV-2, Flu, RSV

Sponsorships